Breakthrough in COVID-19 Prevention: Ensitrelvir Shows Significant Efficacy as Post-Exposure Prophylaxis
In a landmark development for public health, researchers have unveiled results from a major Phase III clinical trial demonstrating that the oral antiviral ensitrelvir significantly reduces the risk of COVID-19…











